| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXHB2300098 | D-0120-NA片 | D-0120-NA | Tablet | Chemical Drugs(1) | Supplementary Application | 2023-04-22 | InventisBio Co Ltd | view | |||
| CXHL2101029 | D-0120-NA片 | D-0120-NA | Tablet | Chemical Drugs(1) | New Drug Application | 2021-04-12 | InventisBio Co Ltd | view | |||
| CXHB2000031 | D-0120-NA片 | D-0120-NA | Tablet | Chemical Drugs | Supplementary Application | 2020-04-16 | 益方生物科技（上海）有限公司 | InventisBio Co Ltd | In Review | 2020-04-15 | view |
| CXHL1700202 | D-0120-NA片 | D-0120-NA | Tablet | Chemical Drugs(1) | New Drug Application | 2017-09-26 | 益方生物科技（上海）有限公司 | InventisBio Co Ltd | Certificate Issued | 2018-03-26 | view |
| CXHL1700203 | D-0120-NA片 | D-0120-NA | Tablet | Chemical Drugs(1) | New Drug Application | 2017-09-26 | 益方生物科技（上海）有限公司 | InventisBio Co Ltd | Certificate Issued | 2018-03-26 | view |